## Abstract EBV‐infected cells and EBV‐associated tumors may evade CTL recognition by defective antigen processing, resulting in poor presentation of CTL epitopes. Since the proteasome is the major source of MHC class I–presented peptides, we analyzed the effect of proteasome inhibitors on the expr
Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein-Barr virus
✍ Scribed by Ann Apolloni; Denis Moss; Robyn Stumm; Scott Burrows; Andreus Suhrbier; Ihor Misko; Chris Schmidt; Tom Sculley
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 641 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Several reports have shown a defective Epstein-Barr virus (EBV)-specific suppressor T cell function in rheumatoid arthritis (RA), suggesting that EBV may have a role in the pathogenesis of RA. EBV-specific T cell regulation was studied in 47 EBV-immune RA patients and in 14 EBV-immune control subjec
## Abstract EBV‐specific cytotoxic T cells (Tc)^1^ induced __in vitro__ have continuously proliferated __in vitro__ for over 9 months. The long‐term maintenance of the Tc growth was dependent on periodic supplementation of both irrediated EBV‐transformed autologous lymphoblastoid cell line (LCL) ce
Tumor cells from NPC patients are regularly and latently infected with EBV. To examine whether the virus serves as target for immune intervention of the cancer, we determined levels of EBV-specific CTLp in peripheral blood from NPC patients, long-term survivors of the cancer and healthy subjects. CT
Epstein-Barr (EB) virus isolates can be classified as type A or type B depending upon the identity of the virus-encoded nuclear antigen EBNA 2; the EBNA 2A and 2B proteins show limited amino-acid homology and induce largely non-crossreactive antibody responses in humans. To examine whether EBNA 2 mi